Coherus Oncology, Inc. Operating Income
Coherus Oncology, Inc. (CHRS) reported Operating Income of -$32.33 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- Coherus Oncology, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$32.33M.
- Coherus Oncology, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$36.15M.
- Coherus Oncology, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$45.88M.
- Coherus Oncology, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$44.33M.
- Coherus Oncology, Inc. operating income (loss) for fiscal 2025 was -$181.13M.
- Coherus Oncology, Inc. operating income (loss) for fiscal 2024 was -$199.65M.
- Coherus Oncology, Inc. operating income (loss) for fiscal 2022 was -$256.88M.
- Coherus Oncology, Inc. operating income (loss) for fiscal 2021 was -$263.86M, a 268.79% decline from fiscal 2020.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$32.33M 10-Q · filed 2026-08-05 | -$68.48M 10-Q · filed 2026-08-05 | -$114.36M derived: sum of 3 quarters · filed 2026-08-05 | -$158.69M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$36.15M 10-Q · filed 2026-05-11 | -$82.03M derived: sum of 2 quarters · filed 2026-05-11 | -$126.36M derived: sum of 3 quarters · filed 2026-05-11 | -$171.85M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$45.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$90.21M derived: sum of 2 quarters · filed 2026-03-09 | -$135.70M derived: sum of 3 quarters · filed 2026-08-05 | -$181.13M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | -$44.33M 10-Q · filed 2025-11-06 | -$89.82M derived: sum of 2 quarters · filed 2026-08-05 | -$135.25M 10-Q · filed 2025-11-06 | -$180.64M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | -$45.49M 10-Q · filed 2026-08-05 | -$90.92M 10-Q · filed 2026-08-05 | -$136.31M derived: sum of 3 quarters · filed 2026-08-05 | -$183.16M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$45.44M 10-Q · filed 2026-05-11 | -$90.82M derived: sum of 2 quarters · filed 2026-05-11 | -$137.68M derived: sum of 3 quarters · filed 2026-05-11 | -$177.30M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | -$45.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$92.24M derived: sum of 2 quarters · filed 2026-03-09 | -$131.87M derived: sum of 3 quarters · filed 2026-03-09 | -$199.65M 10-K · filed 2026-03-09 | -$111.67M 10-K · filed 2025-03-17 | |||
| 2024-09-30 | -$46.86M 10-Q · filed 2025-11-06 | -$6.39M 10-Q · filed 2024-11-06 | -$86.48M derived: sum of 2 quarters · filed 2025-11-06 | -$154.27M 10-Q · filed 2025-11-06 | -$69.42M 10-Q · filed 2024-11-06 | -$235.76M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$39.63M 10-Q · filed 2025-08-07 | -$20.51M 10-Q · filed 2024-08-08 | -$107.41M 10-Q · filed 2025-08-07 | -$63.03M 10-Q · filed 2024-08-08 | -$188.91M derived: sum of 3 quarters · filed 2025-11-13 | -$220.91M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-03-31 | -$67.79M 10-Q · filed 2025-05-12 | -$42.52M 10-Q · filed 2024-05-09 | -$149.28M derived: sum of 2 quarters · filed 2025-11-13 | -$181.29M derived: sum of 3 quarters · filed 2025-11-13 | -$215.83M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2023-12-31 | -$81.49M derived: 8-K 12 month − 10-Q 9 month · filed 2025-11-13 | -$113.50M derived: sum of 2 quarters · filed 2025-11-13 | -$148.04M derived: sum of 3 quarters · filed 2025-11-13 | -$215.79M 8-K · filed 2025-11-13 | -$203.20M 10-K · filed 2024-03-15 | |||
| 2023-09-30 | -$32.01M 10-Q · filed 2024-11-06 | -$66.55M derived: sum of 2 quarters · filed 2024-11-06 | -$134.29M 10-Q · filed 2024-11-06 | -$185.79M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | -$34.54M 10-Q · filed 2024-08-08 | -$102.29M 10-Q · filed 2024-08-08 | -$153.78M derived: sum of 3 quarters · filed 2025-03-17 | -$234.23M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | -$67.75M 10-Q · filed 2024-05-09 | -$119.24M derived: sum of 2 quarters · filed 2025-03-17 | -$199.69M derived: sum of 3 quarters · filed 2025-03-17 | -$243.70M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | -$51.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$131.94M derived: sum of 2 quarters · filed 2025-03-17 | -$175.96M derived: sum of 3 quarters · filed 2025-03-17 | -$256.88M 10-K · filed 2025-03-17 | ||||
| 2022-09-30 | -$80.45M 10-Q · filed 2023-11-06 | -$124.46M derived: sum of 2 quarters · filed 2023-11-06 | -$205.39M 10-Q · filed 2023-11-06 | -$244.93M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-06-30 | -$44.01M 10-Q · filed 2023-08-02 | -$124.94M 10-Q · filed 2023-08-02 | -$164.49M derived: sum of 3 quarters · filed 2024-03-15 | -$197.27M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2022-03-31 | -$80.92M 10-Q · filed 2023-05-08 | -$120.47M derived: sum of 2 quarters · filed 2024-03-15 | -$153.26M derived: sum of 3 quarters · filed 2024-03-15 | -$177.42M derived: sum of 4 quarters · filed 2024-03-15 | ||||
| 2021-12-31 | -$39.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$72.33M derived: sum of 2 quarters · filed 2024-03-15 | -$96.50M derived: sum of 3 quarters · filed 2024-03-15 | -$263.86M 10-K · filed 2024-03-15 | ||||
| 2021-09-30 | -$32.79M 10-Q · filed 2022-11-08 | -$56.95M derived: sum of 2 quarters · filed 2022-11-08 | -$224.31M 10-Q · filed 2022-11-08 | -$207.89M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-06-30 | -$24.16M 10-Q · filed 2022-08-04 | -$191.52M 10-Q · filed 2022-08-04 | -$175.10M derived: sum of 3 quarters · filed 2023-03-06 | -$141.38M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-03-31 | -$167.36M 10-Q · filed 2022-05-05 | -$150.94M derived: sum of 2 quarters · filed 2023-03-06 | -$117.22M derived: sum of 3 quarters · filed 2023-03-06 | -$51.91M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | $16.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $50.14M derived: sum of 2 quarters · filed 2023-03-06 | $115.45M derived: sum of 3 quarters · filed 2023-03-06 | $156.32M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $33.72M 10-Q · filed 2021-11-08 | $99.03M derived: sum of 2 quarters · filed 2021-11-08 | $139.89M 10-Q · filed 2021-11-08 | $184.93M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $65.31M 10-Q · filed 2021-08-05 | $106.18M 10-Q · filed 2021-08-05 | $151.21M derived: sum of 3 quarters · filed 2022-02-23 | $203.05M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $40.87M 10-Q · filed 2021-05-06 | $85.90M derived: sum of 2 quarters · filed 2022-02-23 | $137.74M derived: sum of 3 quarters · filed 2022-02-23 | $165.24M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $45.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $96.87M derived: sum of 2 quarters · filed 2022-02-23 | $124.37M derived: sum of 3 quarters · filed 2022-02-23 | $107.77M 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | $51.84M 10-Q · filed 2020-11-05 | $79.33M derived: sum of 2 quarters · filed 2020-11-05 | $62.73M 10-Q · filed 2020-11-05 | $2.23M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $27.49M 10-Q · filed 2020-08-06 | $10.89M 10-Q · filed 2020-08-06 | -$49.61M derived: sum of 3 quarters · filed 2021-02-25 | -$106.58M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$16.60M 10-Q · filed 2020-05-07 | -$77.10M derived: sum of 2 quarters · filed 2021-02-25 | -$134.07M derived: sum of 3 quarters · filed 2021-02-25 | -$178.98M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$60.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$117.47M derived: sum of 2 quarters · filed 2021-02-25 | -$162.38M derived: sum of 3 quarters · filed 2021-02-25 | -$204.42M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$56.97M 10-Q · filed 2019-11-08 | -$101.88M derived: sum of 2 quarters · filed 2019-11-08 | -$143.91M 10-Q · filed 2019-11-08 | -$190.38M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | -$44.91M 10-Q · filed 2019-08-05 | -$86.94M 10-Q · filed 2019-08-05 | -$133.41M derived: sum of 3 quarters · filed 2020-02-27 | -$190.02M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$42.03M 10-Q · filed 2019-05-09 | -$88.50M derived: sum of 2 quarters · filed 2020-02-27 | -$145.11M derived: sum of 3 quarters · filed 2020-02-27 | -$201.75M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | -$46.47M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$103.08M derived: sum of 2 quarters · filed 2020-02-27 | -$159.72M derived: sum of 3 quarters · filed 2020-02-27 | -$232.14M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | -$56.62M 10-Q · filed 2018-11-08 | -$113.25M derived: sum of 2 quarters · filed 2018-11-08 | -$185.67M 10-Q · filed 2018-11-08 | -$259.13M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | -$56.64M 10-Q · filed 2018-08-08 | -$129.06M 10-Q · filed 2018-08-08 | -$202.51M derived: sum of 3 quarters · filed 2019-02-28 | -$117.90M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | -$72.42M 10-Q · filed 2018-05-10 | -$145.88M derived: sum of 2 quarters · filed 2019-02-28 | -$61.26M derived: sum of 3 quarters · filed 2019-02-28 | -$124.00M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | -$73.46M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $11.16M derived: sum of 2 quarters · filed 2019-02-28 | -$51.58M derived: sum of 3 quarters · filed 2019-02-28 | -$115.93M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | $84.62M 10-Q · filed 2017-11-06 | $21.88M derived: sum of 2 quarters · filed 2017-11-06 | -$42.47M 10-Q · filed 2017-11-06 | -$94.68M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-06-30 | -$62.74M 10-Q · filed 2017-08-07 | -$127.09M 10-Q · filed 2017-08-07 | -$179.29M derived: sum of 3 quarters · filed 2018-03-08 | -$250.51M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-03-31 | -$64.35M 10-Q · filed 2017-05-08 | -$116.56M derived: sum of 2 quarters · filed 2018-03-08 | -$187.78M derived: sum of 3 quarters · filed 2018-03-08 | -$246.67M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2015-12-31 | -$52.21M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$123.42M derived: sum of 2 quarters · filed 2018-03-08 | -$182.32M derived: sum of 3 quarters · filed 2018-03-08 | -$219.07M 10-K · filed 2018-03-08 | ||||
| 2015-09-30 | -$71.22M 10-Q · filed 2016-11-09 | -$130.11M derived: sum of 2 quarters · filed 2016-11-09 | -$166.86M 10-Q · filed 2016-11-09 | -$193.42M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-06-30 | -$58.90M 10-Q · filed 2016-08-09 | -$95.64M 10-Q · filed 2016-08-09 | -$122.20M derived: sum of 3 quarters · filed 2017-03-14 | -$128.63M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-03-31 | -$36.75M 10-Q · filed 2016-05-09 | -$63.31M derived: sum of 2 quarters · filed 2017-03-14 | -$69.73M derived: sum of 3 quarters · filed 2017-03-14 | -$87.67M derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2014-12-31 | -$26.56M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$32.98M derived: sum of 2 quarters · filed 2017-03-14 | -$50.92M derived: sum of 3 quarters · filed 2017-03-14 | -$64.68M 10-K · filed 2017-03-14 | ||||
| 2014-09-30 | -$6.42M 10-Q · filed 2015-11-10 | -$24.36M derived: sum of 2 quarters · filed 2015-11-10 | -$38.12M 10-Q · filed 2015-11-10 | -$48.61M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | -$17.94M 10-Q · filed 2015-08-10 | -$31.70M 10-Q · filed 2015-08-10 | -$42.19M derived: sum of 3 quarters · filed 2016-02-29 | -$48.97M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | -$13.76M 10-Q · filed 2015-05-11 | -$24.25M derived: sum of 2 quarters · filed 2016-02-29 | -$31.03M derived: sum of 3 quarters · filed 2016-02-29 | |||||
| 2013-12-31 | -$10.49M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$17.27M derived: sum of 2 quarters · filed 2016-02-29 | -$35.99M 10-K · filed 2016-02-29 | |||||
| 2013-09-30 | -$6.78M 10-Q · filed 2014-12-15 | -$25.51M 10-Q · filed 2014-12-15 | ||||||
| 2012-12-31 | -$38.52M 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |